Literature DB >> 16640555

Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase.

Gabriel Amitai1, Leonid Gaidukov, Rellie Adani, Shelly Yishay, Guy Yacov, Moshe Kushnir, Shai Teitlboim, Michal Lindenbaum, Peter Bel, Olga Khersonsky, Dan S Tawfik, Haim Meshulam.   

Abstract

We addressed the ability of various organophosphorus (OP) hydrolases to catalytically scavenge toxic OP nerve agents. Mammalian paraoxonase (PON1) was found to be more active than Pseudomonas diminuta OP hydrolase (OPH) and squid O,O-di-isopropyl fluorophosphatase (DFPase) in detoxifying cyclosarin (O-cyclohexyl methylphosphonofluoridate) and soman (O-pinacolyl methylphosphonofluoridate). Subsequently, nine directly evolved PON1 variants, selected for increased hydrolytic rates with a fluorogenic diethylphosphate ester, were tested for detoxification of cyclosarin, soman, O-isopropyl-O-(p-nitrophenyl) methyl phosphonate (IMP-pNP), DFP, and chlorpyrifos-oxon (ChPo). Detoxification rates were determined by temporal acetylcholinesterase inhibition by residual nonhydrolyzed OP. As stereoisomers of cyclosarin and soman differ significantly in their acetylcholinesterase-inhibiting potency, we actually measured the hydrolysis of the more toxic stereoisomers. Cyclosarin detoxification was approximately 10-fold faster with PON1 mutants V346A and L69V. V346A also exhibited fourfold and sevenfold faster hydrolysis of DFP and ChPo, respectively, compared with wild-type, and ninefold higher activity towards soman. L69V exhibited 100-fold faster hydrolysis of DFP than the wild-type. The active-site mutant H115W exhibited 270-380-fold enhancement toward hydrolysis of the P-S bond in parathiol, a phosphorothiolate analog of parathion. This study identifies three key positions in PON1 that affect OP hydrolysis, Leu69, Val346 and His115, and several amino-acid replacements that significantly enhance the hydrolysis of toxic OPs. GC/pulsed flame photometer detector analysis, compared with assay of residual acetylcholinesterase inhibition, displayed stereoselective hydrolysis of cyclosarin, soman, and IMP-pNP, indicating that PON1 is less active toward the more toxic optical isomers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16640555     DOI: 10.1111/j.1742-4658.2006.05198.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  20 in total

1.  Catalytic Soman Scavenging by the Y337A/F338A Acetylcholinesterase Mutant Assisted with Novel Site-Directed Aldoximes.

Authors:  Zrinka Kovarik; Nikolina Maček Hrvat; Maja Katalinić; Rakesh K Sit; Alexander Paradyse; Suzana Žunec; Kamil Musilek; Valery V Fokin; Palmer Taylor; Zoran Radić
Journal:  Chem Res Toxicol       Date:  2015-04-16       Impact factor: 3.739

Review 2.  In the light of directed evolution: pathways of adaptive protein evolution.

Authors:  Jesse D Bloom; Frances H Arnold
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-15       Impact factor: 11.205

3.  Characterization of human paraoxonase 1 variants suggest that His residues at 115 and 134 positions are not always needed for the lactonase/arylesterase activities of the enzyme.

Authors:  Priyanka Bajaj; Rajan K Tripathy; Geetika Aggarwal; Abhay H Pande
Journal:  Protein Sci       Date:  2013-10-26       Impact factor: 6.725

4.  Enzymatic detoxification of organophosphorus pesticides and related toxicants.

Authors:  Karla Alejo-González; Erik Hanson-Viana; Rafael Vazquez-Duhalt
Journal:  J Pestic Sci       Date:  2018-02-28       Impact factor: 1.519

5.  Computational Modeling of Human Paraoxonase 1: Preparation of Protein Models, Binding Studies, and Mechanistic Insights.

Authors:  Toby T Sanan; Sivaramakrishnan Muthukrishnan; Jeremy M Beck; Peng Tao; Carrigan J Hayes; Tamara C Otto; Douglas M Cerasoli; David E Lenz; Christopher M Hadad
Journal:  J Phys Org Chem       Date:  2010-04-01       Impact factor: 2.391

Review 6.  Organophosphate-Hydrolyzing Enzymes as First-Line of Defence Against Nerve Agent-Poisoning: Perspectives and the Road Ahead.

Authors:  A R Satvik Iyengar; Abhay H Pande
Journal:  Protein J       Date:  2016-12       Impact factor: 2.371

7.  Directed evolution of hydrolases for prevention of G-type nerve agent intoxication.

Authors:  Rinkoo D Gupta; Moshe Goldsmith; Yacov Ashani; Yair Simo; Gavriel Mullokandov; Hagit Bar; Moshe Ben-David; Haim Leader; Raanan Margalit; Israel Silman; Joel L Sussman; Dan S Tawfik
Journal:  Nat Chem Biol       Date:  2011-01-09       Impact factor: 15.040

8.  Crystal structures of brain group-VIII phospholipase A2 in nonaged complexes with the organophosphorus nerve agents soman and sarin.

Authors:  Todd M Epstein; Uttamkumar Samanta; Stephen D Kirby; Douglas M Cerasoli; Brian J Bahnson
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

9.  Crystal structures of human group-VIIA phospholipase A2 inhibited by organophosphorus nerve agents exhibit non-aged complexes.

Authors:  Uttamkumar Samanta; Stephen D Kirby; Prabhavathi Srinivasan; Douglas M Cerasoli; Brian J Bahnson
Journal:  Biochem Pharmacol       Date:  2009-04-24       Impact factor: 5.858

10.  In vivo administration of BL-3050: highly stable engineered PON1-HDL complexes.

Authors:  Leonid Gaidukov; Dganit Bar; Shiri Yacobson; Esmira Naftali; Olga Kaufman; Rinat Tabakman; Dan S Tawfik; Etgar Levy-Nissenbaum
Journal:  BMC Clin Pharmacol       Date:  2009-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.